Innate Pharma SA reported that the initial patient has been dosed in its Phase 1 trial (NCT06781983), evaluating the safety and tolerability of IPH4502, a novel Antibody-Drug Conjugate (ADC), in individuals with advanced solid tumors expressing...
Novo Nordisk, a prominent global healthcare firm, reported topline outcomes from a phase 1b/2a clinical trial involving amycretin, a unimolecular GLP-1 and amylin receptor agonist designed for weekly subcutaneous administration. The study...
Rakuten Medical, Inc., a worldwide biotechnology firm focused on developing and commercializing precision, cell-targeting Alluminox platform-based photoimmunotherapy, declared the launch of its global multi-regional phase 3 clinical trial...
Jaguar Health, Inc. (Jaguar) affiliated companies Napo Pharmaceuticals (Napo) and Napo Therapeutics announced that the first patient has received a dose in the independent investigator-led POC trial of crofelemer, Jaguar's innovative plant-derived...
ENA Respiratory, a clinical-stage pharmaceutical firm focused on creating antiviral host defense immune boosters to reduce the effects of viral respiratory infections in vulnerable groups, reports that it has successfully finalized dosing for the...
Tris Pharma, Inc. (Tris), a biopharmaceutical company in the commercial stage, revealed encouraging topline findings from its ALLEVIATE-1 crucial Phase 3 clinical trial assessing cebranopadol, an experimental treatment, for addressing moderate-to...
Guangzhou Fermion Technology Co., Ltd., an AI-focused biotech firm in clinical development, and Simcere Pharmaceutical Group Limited, a pharmaceutical entity, have announced a collaboration to advance a clinical-stage pain treatment asset, FZ002...
PulseSight Therapeutics SAS, a biotech firm focused on ophthalmology that creates groundbreaking non-viral vector therapies utilizing minimally-invasive delivery methods, has announced it has filed a Clinical Trial Authorization (CTA) with the...
Lyndra Therapeutics, a biopharmaceutical company in the clinical stage, has formed a strategic partnership with Thermo Fisher Scientific Inc., wherein Thermo Fisher will offer global clinical research and commercial manufacturing services to...
ProMIS Neurosciences Inc., a biotechnology company at the clinical stage aimed at creating precise therapies for neurodegenerative diseases, announced the start of its phase 1b clinical trial (PRECISE-AD) assessing its primary therapeutic...
, CDSCO.jpg)
